FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054093886> ?p ?o ?g. }

• W2054093886 endingPage "471" @default.
• W2054093886 startingPage "455" @default.
• W2054093886 abstract "The studies associating infections by herpes simplex virus type 2 (HSV-2) with carcinoma of the human uterine cervix are reviewed within the context of three possible interpretations. Extensive seroepidemiologic evidence indicates that the virus does not grow preferentially in neoplastic tissue, nor is the association of HSV-2 with cervical carcinoma a reflection of their independent relationship to promiscuity. While a number of infectious agents, including other viruses, are associated with cervical atypia, only HSV-2 is a significant risk factor for CIS. In vitro transformation data supporting the oncogenic potential of the virus are summarized, and evidence is presented that an antigen designated ICP 10/AG-4 is a valid candidate for the role of a virus-encoded protein involved in the maintenance of a transformed phenotype. Antibody to AG-4 is IgM, and it is detected by microquantitative complement fixation. With this assay, it is demonstrated that conversion to anti-AG-4 occurs during primary infection with HSV-2; however, it is transient. In testing 1325 patients, a correlation was observed between antibody to AG-4 and cervical carcinoma. Thus, whereas only 11.7% of controls and 7.7% of patients with cancer at other sites are AG-4 seropositive, as many as 49.6% of patients with dysplasia, 63% of those with CIS, and 72.7% of those with invasive cancer are positive for the antibody. Antibody to AG-4 is related to tumor growth. This is evidence by 1) retrospective analyses demonstrating that the proportion of AG-4 seropositive individuals is directly correlated to the state of the disease and 2) prospective study of 209 patients demonstrating loss of antibody in patients with a successfully removed tumor mass and reappearance of AG-4 antibody in cancer recurrence. The possible use of AG-4 (or its antibody) in the diagnosis and monitoring of cervical carcinoma and its treatment is discussed." @default.
• W2054093886 created "2016-06-24" @default.
• W2054093886 creator A5004317823 @default.
• W2054093886 creator A5023205151 @default.
• W2054093886 creator A5045787640 @default.
• W2054093886 creator A5070959425 @default.
• W2054093886 date "1981-07-15" @default.
• W2054093886 modified "2023-10-04" @default.
• W2054093886 title "Viruses and gynecologic cancers: Herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity" @default.
• W2054093886 cites W1482313511 @default.
• W2054093886 cites W1496085373 @default.
• W2054093886 cites W1534014686 @default.
• W2054093886 cites W1555751159 @default.
• W2054093886 cites W1883510958 @default.
• W2054093886 cites W1896109886 @default.
• W2054093886 cites W19254763 @default.
• W2054093886 cites W1965904631 @default.
• W2054093886 cites W1971224110 @default.
• W2054093886 cites W1973795862 @default.
• W2054093886 cites W1987914647 @default.
• W2054093886 cites W1988994098 @default.
• W2054093886 cites W1999211350 @default.
• W2054093886 cites W2000793708 @default.
• W2054093886 cites W2013284471 @default.
• W2054093886 cites W2017224376 @default.
• W2054093886 cites W2026293541 @default.
• W2054093886 cites W2027261968 @default.
• W2054093886 cites W2036007109 @default.
• W2054093886 cites W2050936673 @default.
• W2054093886 cites W2081063058 @default.
• W2054093886 cites W2125297340 @default.
• W2054093886 cites W2255341698 @default.
• W2054093886 cites W2270551465 @default.
• W2054093886 cites W2286260700 @default.
• W2054093886 cites W2343496173 @default.
• W2054093886 cites W2416520012 @default.
• W2054093886 doi "https://doi.org/10.1002/1097-0142(19810715)48:1+<455::aid-cncr2820481306>3.0.co;2-2" @default.
• W2054093886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7023662" @default.
• W2054093886 hasPublicationYear "1981" @default.
• W2054093886 type Work @default.
• W2054093886 sameAs 2054093886 @default.
• W2054093886 citedByCount "37" @default.
• W2054093886 countsByYear W20540938862016 @default.
• W2054093886 countsByYear W20540938862020 @default.
• W2054093886 crossrefType "journal-article" @default.
• W2054093886 hasAuthorship W2054093886A5004317823 @default.
• W2054093886 hasAuthorship W2054093886A5023205151 @default.
• W2054093886 hasAuthorship W2054093886A5045787640 @default.
• W2054093886 hasAuthorship W2054093886A5070959425 @default.
• W2054093886 hasBestOaLocation W20540938861 @default.
• W2054093886 hasConcept C121608353 @default.
• W2054093886 hasConcept C126322002 @default.
• W2054093886 hasConcept C142724271 @default.
• W2054093886 hasConcept C147483822 @default.
• W2054093886 hasConcept C151730666 @default.
• W2054093886 hasConcept C152669594 @default.
• W2054093886 hasConcept C159047783 @default.
• W2054093886 hasConcept C159654299 @default.
• W2054093886 hasConcept C203014093 @default.
• W2054093886 hasConcept C2522874641 @default.
• W2054093886 hasConcept C2775894508 @default.
• W2054093886 hasConcept C2777546739 @default.
• W2054093886 hasConcept C2777661416 @default.
• W2054093886 hasConcept C2777740455 @default.
• W2054093886 hasConcept C2778220009 @default.
• W2054093886 hasConcept C2779343474 @default.
• W2054093886 hasConcept C2781196997 @default.
• W2054093886 hasConcept C2993273003 @default.
• W2054093886 hasConcept C45189115 @default.
• W2054093886 hasConcept C555283112 @default.
• W2054093886 hasConcept C71924100 @default.
• W2054093886 hasConcept C86803240 @default.
• W2054093886 hasConceptScore W2054093886C121608353 @default.
• W2054093886 hasConceptScore W2054093886C126322002 @default.
• W2054093886 hasConceptScore W2054093886C142724271 @default.
• W2054093886 hasConceptScore W2054093886C147483822 @default.
• W2054093886 hasConceptScore W2054093886C151730666 @default.
• W2054093886 hasConceptScore W2054093886C152669594 @default.
• W2054093886 hasConceptScore W2054093886C159047783 @default.
• W2054093886 hasConceptScore W2054093886C159654299 @default.
• W2054093886 hasConceptScore W2054093886C203014093 @default.
• W2054093886 hasConceptScore W2054093886C2522874641 @default.
• W2054093886 hasConceptScore W2054093886C2775894508 @default.
• W2054093886 hasConceptScore W2054093886C2777546739 @default.
• W2054093886 hasConceptScore W2054093886C2777661416 @default.
• W2054093886 hasConceptScore W2054093886C2777740455 @default.
• W2054093886 hasConceptScore W2054093886C2778220009 @default.
• W2054093886 hasConceptScore W2054093886C2779343474 @default.
• W2054093886 hasConceptScore W2054093886C2781196997 @default.
• W2054093886 hasConceptScore W2054093886C2993273003 @default.
• W2054093886 hasConceptScore W2054093886C45189115 @default.
• W2054093886 hasConceptScore W2054093886C555283112 @default.
• W2054093886 hasConceptScore W2054093886C71924100 @default.
• W2054093886 hasConceptScore W2054093886C86803240 @default.
• W2054093886 hasIssue "S1" @default.
• W2054093886 hasLocation W20540938861 @default.
• W2054093886 hasLocation W20540938862 @default.
• W2054093886 hasOpenAccess W2054093886 @default.

• next